—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
GENE THERAPY《基因治疗》
月刊 - 英国
  • GENE THERAPY《基因治疗》
  • SCIE外文期刊
  • 期发文量8
  • 国人占比8.70%
  • 维普目次
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:3区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:1
    环比增速:0.00%
  • 期刊信息

  • 研究方向:医学-BIOTECHNOLOGY APPLIED MICROBIOLOGY 生物工程与应用微生物;BIOCHEMISTRY MOLECULAR BIOLOGY 生化与分子生物学;GENETICS HEREDITY 遗传学;MEDICINE, RESEARCH EXPERIMENTAL 医学:研究与实验
  • 国际刊号:ISSN0969-7128;EISSN1476-5462
  • 期刊语言:英语
    出版地区:英国
  • 投稿网址:https://mts-gt.nature.com/cgi-bin/main.plex
  • 电子邮箱:
  • 期刊官网:https://www.nature.com/gt/
  • 作者指南:
  • 出版商网址:http://www.nature.com
  • 出版地址:NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
  • 期刊简介:GENE THERAPY《基因治疗》(月刊). Gene Therapy covers both the research and clinical applications of novel therapeutic techniques based on a genetic component. Over the last few decades, significant advances in technologies ranging from identifying novel genetic targets that cause disease through to clinical studies, which show therapeutic benefit, have elevated this multidisciplinary field to the forefront of modern medicine.

  • 万维提示


  • 1、投稿方式:在线投稿。

    2、期刊网址:https://www.nature.com/gt/

    3、投稿网址:

    https://mts-gt.nature.com/cgi-bin/main.plex

    4、官网邮箱:genetherapy@nature.com(编辑部)

    editorinchiefgt@gmail.com(主编)

    5、期刊刊期:月刊,一年出版十二期。

    2021522日星期六

                                 

     

    投稿须知【官网信息】

     

    Guide to Authors

    ABOUT THE JOURNAL

    Aims and Scope Gene Therapy covers both the research and clinical applications of novel therapeutic techniques based on a genetic component. Over the last few decades, significant advances in technologies ranging from identifying novel genetic targets that cause disease through to clinical studies, which show therapeutic benefit, have elevated this multidisciplinary field to the forefront of modern medicine.

    Gene Therapy covers all aspects of gene therapy as applied to human disease, including:

    preliminary studies which reveal novel genetic targets or strategies that improve a disease phenotype (Note: studies showing the mechanistic role of genetic elements alone, will be considered if significant therapeutic benefit or novelty is shown)

    the development of novel techniques for gene therapy research and improvements on established tools

    preclinical animal model systems and validation studies

    gene-based vaccine development and applications

    genetically engineered cellular models that can advance the validation of novel therapeutic targets, and drug discovery especially those using high-throughput applications and 3D modelling

    cell-based therapies including all aspects of stem cells and genetically modified cellular approaches (especially CRISPR and other gene editing strategies), including biobanking studies

    clinical trial reports which have significant impact for the field

    novel genetic biomarkers of disease susceptibility or disease progression with extensive scientific validation

    Industry sector pipeline profiles or commercial implications of gene therapies

    Regulatory landscapes and legislative issues pertaining to different global regions

    Journal Details Editor-in-Chief: Janine Scholefield, Council for Scientific and Industrial Research, South Africa, editorinchiefgt@gmail.com

    Editorial office: Springer Nature, The Campus, 4 Crinan Street, London, UK, genetherapy@nature.com

    Frequency: 12 issues a year

    Abstracted in: BIOSIS Google Scholar Medline OCLC Science Citation Index Science Citation Index Expanded (SciSearch) Current Contents/Life Sciences SCOPUS Summon by ProQuest EBSCO Academic Search EBSCO Advanced Placement Source EBSCO Biomedical Reference Collection EBSCO STM Source ProQuest Biological Science Database ProQuest Central ProQuest Health & Medial Collection ProQuest Health Research Premium Collection ProQuest Medical Database ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Public Health Database ProQuest Research Library ProQuest SciTech Premium Collection EMBACE CNKI

    Please note: for initial submissions we are happy to assess manuscripts in any format, as long as all the relevant sections are included and the manuscript can be easily assessed by our Editors and Reviewers. However, all revised submissions must adhere to the individual article formats and journal rules as clearly described below.

    Peer Review Taxonomy: Gene Therapy is participating in a pilot of STM's Working Group on Peer Review Taxonomy. Please see How to Submit for more information.

    ARTICLE TYPE SPECIFICATIONS

    ARTICLE DESCRIPTION

    SPECIFICATION

    Article (including Enabling Technologies) An Article is a substantial, in-depth, novel research study of interest to the readership of the journal. The structure an Article should follow is detailed below.

    Unstructured abstract max 200 words;

    Main body of text (excluding abstract, references, figures/tables) not to exceed 8,000 words;

    Review Article Reviews in Gene Therapy aim to provide accessible, authoritative overviews of a field or topic. Review articles should communicate a sense of enthusiasm, weaving background information with the latest advances, and placing both of these elements in the context of the rest of the field. The abstract describes what the article is about in a succinct, easily digestible way. It should not contain specialist details, abbreviations, references or figure citations. References should concentrate on significant original research papers.

    Unstructured abstract max 200 words;

    Main body of text (excluding abstract, references, figures/tables) not to exceed 4,000 words;

    Liberal use of tables or figures is encouraged

    Max 100 references

    News These should be shorter and more personal than reviews and comment on an individual paper or a specific area of research.

    No abstract required;

    Main body of text (excluding references, figures/tables) not to exceed 1,000 words;

    Max 3 tables or figures

    Max 20 references

    Brief Communication

    A Brief Communication reports a concise study of high quality and broad interest. These should be arranged under the headings: Abstract, Introduction, Materials & Methods, Results and Discussion where possible.

    Unstructured abstract max 200 words;

    Main body of text (excluding abstract, references, figures/tables) not to exceed 3,000 words;

    Max 6 tables or figures

    Max 50 references

    Editorial These will be solicited by the editors but suggestions for such material are very welcome.

    No abstract required;

    Main body of text (excluding abstract, references, figures/tables) not to exceed 1,500 words;

    Max 2 tables or figures

    Max 5 references

    Comment

    These can discuss a recent paper or portray your view on a topical or controversial subject in the field.

    No abstract required;

    Main body of text (excluding abstract, references, figures/tables) not to exceed 1,500 words;

    Max 2 tables or figures

    Max 20 references

    Perspective

    Perspectives are a hybrid between a commentary and a review, providing an opinion-driven perspective on a particular research topic or field of interest to the Gene Therapy readership. Authors should present a (provocative) view that can be supported by data and literature with the goal of sparking debate and stimulating future research avenues.

    No abstract required

    Main body of text (excluding abstract, references, figures/tables) not to exceed 2,000 words;

    Max 4 tables or figures

    Max 25 references

    Images

    We would like to invite authors to submit images for potential use on the journal’s front cover or to be featured on the journal’s website and on the journal’s social media platforms. These should be either sent to the Editorial Office at genetherapy@nature.com or supplied as part of a manuscript submission, uploaded as a separate file and mention made in the Cover Letter.

    Each image must be supplied with a title and ownership details (name and institution) and conform to the following formatting requirements:

    Colour mode = CMYK (not RGB)

    File format = .tif, .eps or .jpg

    Minimum resolution = 300dpi at 525px wide by 300px high

    PREPARATION OF ARTICLES

    House Style: Authors should adhere to the following formatting guidelines

    Text should be double spaced with a wide margin.

    All pages and lines are to be numbered.

    Do not make rules thinner than 1px (0.36mm).

    Use a coarse hatching pattern rather than shading for tints in graphs.

    Colour should be distinct when being used as an identifying tool.

    Commas, not spaces should be used to separate thousands.

    At first mention of a manufacturer, the town (and state if USA) and country should be provided.

    Statistical methods: For normally distributed data, mean (SD) is the preferred summary statistic. Relative risks should be expressed as odds ratios with 95% confidence interval. To compare two methods for measuring a variable the method of Bland & Altman (1986, Lancet 1, 307–310) should be used; for this, calculation of P only is not appropriate.

    Units: Use metric units (SI units) as fully as possible. Preferably give measurements of energy in kiloJoules or MegaJoules with kilocalories in parentheses (1 kcal = 4.186kJ). Use % throughout.

    Abbreviations: On first using an abbreviation place it in parentheses after the full item. Very common abbreviations such as FFA, RNA, need not be defined. Note these abbreviations: gram g; litre l; milligram mg; kilogram kg; kilojoule kJ; megajoule MJ; weight wt; seconds s; minutes min; hours h. Do not add ‘s’ for plural units. Terms used less than four times should not be abbreviated.

    Please note that articles must contain the following components. Please see below for further details:

    Cover letter

    Title page (excluding acknowledgements)

    Abstract

    Introduction

    Materials (or Patients) and Methods

    Results

    Discussion

    Acknowledgements

    Conflict of Interest

    References

    Figure legends

    Tables

    Figures

    Reports of clinical trials must adhere to the registration and reporting requirements listed in the Editorial Policies.

    Cover Letter

    The uploaded covering letter must state the material is original research, has not been previously published and has not been submitted for publication elsewhere while under consideration. If the manuscript has been previously considered for publication in another journal, please include the previous reviewer comments, to help expedite the decision by the Editorial team.

    ……

    更多详情:

    https://www.nature.com/gt/authors-and-referees/gta







欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码